New antibiotic formula aims to protect kidneys in early trial
Knowledge-focused
Not yet recruiting
This early-stage study tests whether a new formulation of the antibiotic polymyxin B (VRP-034) causes less kidney injury than the current version. About 48 healthy adult men will receive single or multiple doses of either the new or standard drug. Researchers will measure kidney …
Phase: PHASE1 • Sponsor: Venus Remedies Limited • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC